IL135018A0 - Treatment of stress and preconditioning against stress - Google Patents

Treatment of stress and preconditioning against stress

Info

Publication number
IL135018A0
IL135018A0 IL13501898A IL13501898A IL135018A0 IL 135018 A0 IL135018 A0 IL 135018A0 IL 13501898 A IL13501898 A IL 13501898A IL 13501898 A IL13501898 A IL 13501898A IL 135018 A0 IL135018 A0 IL 135018A0
Authority
IL
Israel
Prior art keywords
radiation
ozone
stress
mild heating
oxygen gas
Prior art date
Application number
IL13501898A
Other languages
English (en)
Original Assignee
Vasogen Ireland Ltd
Ct De Rech Du Ct Hospitalier D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2218625 external-priority patent/CA2218625A1/en
Priority claimed from CA 2230836 external-priority patent/CA2230836A1/en
Application filed by Vasogen Ireland Ltd, Ct De Rech Du Ct Hospitalier D filed Critical Vasogen Ireland Ltd
Publication of IL135018A0 publication Critical patent/IL135018A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Magnetic Heads (AREA)
  • Dental Preparations (AREA)
  • Saccharide Compounds (AREA)
IL13501898A 1997-09-12 1998-09-11 Treatment of stress and preconditioning against stress IL135018A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5878297P 1997-09-12 1997-09-12
US5917297P 1997-09-17 1997-09-17
CA 2218625 CA2218625A1 (en) 1997-09-12 1997-10-20 Stress treatment and preconditioning against stress
CA 2230836 CA2230836A1 (en) 1998-02-27 1998-02-27 Inducing resistance to ischemic stresses
PCT/CA1998/000869 WO1999013890A1 (en) 1997-09-12 1998-09-11 Treatment of stress and preconditioning against stress

Publications (1)

Publication Number Publication Date
IL135018A0 true IL135018A0 (en) 2001-05-20

Family

ID=27427399

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13501898A IL135018A0 (en) 1997-09-12 1998-09-11 Treatment of stress and preconditioning against stress
IL13501498A IL135014A0 (en) 1997-09-12 1998-09-11 A pharmaceutical composition for treating stress comprising pretreated blood
IL135018A IL135018A (en) 1997-09-12 2000-03-12 Use of stressed blood in a medicament for treating stress and preconditioning against stress

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL13501498A IL135014A0 (en) 1997-09-12 1998-09-11 A pharmaceutical composition for treating stress comprising pretreated blood
IL135018A IL135018A (en) 1997-09-12 2000-03-12 Use of stressed blood in a medicament for treating stress and preconditioning against stress

Country Status (13)

Country Link
EP (1) EP1011696B1 (ru)
JP (1) JP4141636B2 (ru)
AT (1) ATE253922T1 (ru)
AU (1) AU741181B2 (ru)
DE (1) DE69819749T2 (ru)
DK (1) DK1011696T3 (ru)
EA (1) EA003232B1 (ru)
ES (1) ES2210814T3 (ru)
HK (1) HK1031322A1 (ru)
IL (3) IL135018A0 (ru)
NZ (1) NZ503770A (ru)
PT (1) PT1011696E (ru)
WO (1) WO1999013890A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045124B1 (en) 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
EP1146885B1 (en) * 1999-01-12 2003-05-28 Centre De Recherche Du Centre Hospitalier De L'Universite De Montreal Pre-conditioning against cell death
CA2271190A1 (en) 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
WO2001019318A1 (en) * 1999-09-16 2001-03-22 Vasogen Ireland Limited Apparatus and process for conditioning mammalian blood
JP2003510284A (ja) * 1999-09-24 2003-03-18 バソジェン アイルランド リミテッド アテローム性動脈硬化症の処置のための併用療法
CA2296997A1 (en) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
CA2460076A1 (en) * 2001-09-18 2003-03-27 Vasogen Ireland Limited Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE350046T1 (de) * 1992-02-07 2007-01-15 Vasogen Ireland Ltd Verwendung von blut mit erhöhter stickoxidkonzentration zur herstellung eines medikaments
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
JPH08652A (ja) * 1994-06-24 1996-01-09 Oskar:Kk 男性機能回復補助器具
NZ306395A (en) * 1995-05-05 2000-02-28 Vasogen Inc Treatment of blood to remove symptoms of vascular disorders by elevation of temperature, ultraviolet radiation or treatment with an oxidative environment
JPH09227394A (ja) * 1995-12-22 1997-09-02 Taisho Pharmaceut Co Ltd 経口投与用組成物

Also Published As

Publication number Publication date
DE69819749D1 (de) 2003-12-18
DE69819749T2 (de) 2004-09-30
IL135018A (en) 2006-06-11
AU741181B2 (en) 2001-11-22
NZ503770A (en) 2002-10-25
JP2001516723A (ja) 2001-10-02
AU9148098A (en) 1999-04-05
EP1011696A1 (en) 2000-06-28
JP4141636B2 (ja) 2008-08-27
PT1011696E (pt) 2004-03-31
HK1031322A1 (en) 2001-06-15
EA200000312A1 (ru) 2001-04-23
EA003232B1 (ru) 2003-02-27
WO1999013890A1 (en) 1999-03-25
ATE253922T1 (de) 2003-11-15
EP1011696B1 (en) 2003-11-12
ES2210814T3 (es) 2004-07-01
IL135014A0 (en) 2001-05-20
DK1011696T3 (da) 2004-03-15

Similar Documents

Publication Publication Date Title
UA32429C2 (ru) Средство для лечения недержания мочи
BG101284A (en) Compounds and methods for cancer treatment
UY24805A1 (es) Peptidos y compuestos que se enlazan al receptor de la trombopoyetina
GB2290479B (en) Medical appliance for intermittent compression treatment
BR9405763A (pt) Processo para tratar fluido corpóreo processo para tratar produto de sangue e processo para fornecer produtos de sangue a paciente
MX9300607A (es) Aparato y metodo para tratamiento intersticial.
BR9916879A (pt) Composição e método para tratamento do câncer utilizando óleos essenciais vegetais naturais
ES2196530T3 (es) Compuestos de ruptura para inactivar patogenos.
IL135018A0 (en) Treatment of stress and preconditioning against stress
ES2157833A1 (es) Procedimiento para el tratamiento de suelas de zapatos mediante radiacion ultravioleta combinada con ozono.
ES2164914T3 (es) Medicamentos de inmunoterapia que contienen anticuerpos que detectan especificamente el antigeno mhcii del paciente a tratar.
AU2566295A (en) Photodynamic conjugates with biocidal properties
EP0728219A4 (en) WET TREATMENT OF LEATHER AND FUR
GB2334676A (en) Use of ozone for treating diseases of body cavity tissues and apparatus therefor
MY120530A (en) Combination preparation for use in dementia
ES2046944B1 (es) Procedimiento para la destruccion de microorganismos y enzimas mediante la aplicacion combinada de calor y ultrasonidos bajo presion: proceso mts (mano-termo-sonicacion).
SG49210A1 (en) Composition for use in the treatment f tumours and the immunization of organisms against tumours
PL336163A1 (en) Application of oligomeric cartilage intercellular substance protein in treating rheumatologic arthritis
AU1275400A (en) Method and apparatus for treating contaminated waste
EP0569531A4 (en) STABILIZED ANTIBODY FRAGMENTS.
UA32241A (ru) Способ лечения воспалительных процессов экспериментальных животных
EP0321094A3 (en) Treatment of factor viii inhibitors
UA7955A (ru) Способ лечения туберкулеза легких
Li et al. Failure analysis of bi-metal band saw blades
UA8280A (ru) Способ лечения псориаза

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees